Cantourage Group SE, a leading cannabis company based in Berlin, has announced record revenue for the third quarter of 2024, highlighting the booming potential of the European medical cannabis market. The company’s CEO, Philip Schetter, emphasizes the profitability and growth potential of medical cannabis, particularly in Germany, and predicts a continued rise in cannabis therapy adoption.